About

Pangaea is a South San Francisco and London based provider of a novel AI-driven product for characterizing patients by automatically discovering their clinical signatures (which clinicians currently ascertain manually) for 4,000 hard-to-diagnose conditions in a privacy-preserving and scalable manner across 140,000 healthcare providers and pharmaceutical companies globally. This has clinically proven to discover 22x more undiagnosed, misdiagnosed and miscoded patients; discover new insights; halve treatment costs; and drive sustainable collaborations between healthcare and the pharmaceutical industry. The founders (Dr. Vibhor Gupta and Prof. Yike Guo) have attracted over $200 million through their research. The company is advised by Lord David Prior (former Chairman of NHS England), Mr. Andy Palmer (former Head of Systems Integration at Novartis), Dr. Thomas Dyrberg (former Managing Partner, Novo Holdings) and has published its work in high-impact, peer-reviewed journals and conferences, available at www.pangaeadata.ai/insights/.